Keywords: Roche, RoActemra, Rheumatoid arthritis, UK, NICE

UK’s NICE provisionally backs wider use of Roche’s RoActemra for rheumatoid arthritis

Article | 07 October 2011

Print This

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today opened a consultation on draft ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in